Optimizing Quality of Life across Kidney and Urinary Tract Health
This session explores innovative strategies for optimizing quality of life across complex nephrological and urological care pathways, from lifelong chronic management to advanced oncology. The presentation of new clinical data and personalized treatment methodologies emphasizes actionable advancements aimed at improving long-term patient outcomes.
Speakers and topics
- Lisa Örtqvist (Dept. of Women's and Children's Health)
Life long health and quality of life in bladder exstrophy patients. Exploring the lifelong journey of individuals with bladder exstrophy, highlighting key medical and psychosocial factors that define their health and quality of life from childhood into adulthood.
- Emilie Flaberg (Dept. of Oncology-Pathology)
Evolving Landscape of Systemic Therapy in Advanced Bladder Cancer – and the Search for Biomarkers - A brief overview of the evolving systemic treatment landscape in advanced bladder cancer and the potential of tissue-based multiplex immunofluorescence cell profiling for biomarker discovery.
- Juhana Rautiola (Dept. of Molecular Medicine and Surgery)
Towards personalized treatment of muscle invasive bladder cancer: integrating clinical and molecular biomarkers to predict pathological complete response - Predicting pathological complete response after neoadjuvant treatment in muscle invasive bladder cancer would support future organ-sparing strategies as an option to cystectomy.
- Anders Ternhag (Dept. of Medicine, Solna)
Temocillin: A New Antibiotic on the Swedish Market for the Treatment of UTIs - Presenting the Swedish multicenter clinical trial on temocillin and discussing how the resistance-selecting properties of a new antibiotic should be weighed in the risk-benefit analysis.
- Eleni Aklillu (Dept. of Global Public Health)
Challenges in the diagnosis, treatment and control of female urogenital genital schistosomiasis in sub-Saharan Africa - A presentation highlighting the ongoing research and strategies for integrating female genital schistosomiasis services into primary health care and improving women's health outcomes.
- Sigrid Lundberg (Dept. of Clinical Sciences, Danderyd Hospital)
IgA Nephropathy and Personalized Treatment for Glomerulonephritis - Integrating systemic biomarkers with large-scale registry data holds the potential to transform the management of IgA nephropathy and enable personalized medicine.
- Fredrik Piehl (Dept. of Clinical Neuroscience)
Precision Medicine in MS: Optimizing the Benifit-Risk Balance - Modern therapies suppress active MS inflammation but also predispose patients to recurrent infections due to systemic immunosuppression.
- Gert Helgesson (Dept. of Learning, Informatics, Management and Ethics)
Ethics in screening - While screening aims to reduce mortality, there is a risk of overdiagnosis. This talk addresses the ethical complexities in cancer screening.